The Institutional Biosafety Committee (IBC) at Nemours oversees the use of recombinant DNA, infectious agents and biohazardous materials in the course of research. To assure proper oversight, Principal Investigators (PIs) must register their research projects with the IBC prior to funds being made available for the project.
Registration is completed using an online form:
PIs are required to provide the IBC with:
Notification from the IBC regarding the submission will be returned by email.
IBC registration is necessary to assure that PIs have sufficient biosafety training to carry out the proposed research, and to confirm that work will be carried out at the appropriate biosafety level (BSL) and with appropriate safeguards in place.
PIs are responsible for registering their research activities.
Principal Investigators (PIs), the institutions where they work, and the Institutional Biosafety Committees (IBCs) at those institutions are partners in assuring the safe conduct of research. In general, the roles and responsibilities of each are outlined below.
The PI is responsible for full compliance with regulations in the conduct of research and for ensuring that the reporting requirements are fulfilled and will be held accountable for any reporting lapses.
PIs are required to:
Before research begins, PIs will:
During research, PIs will:
The institution (Nemours) establishes policies and procedures to ensure the safe conduct of research involving biohazardous material in compliance with regulatory guidelines. This includes establishing an IBC. It also provides for appropriate training regarding biosafety and files required reports with the NIH.
The institution will:
At Nemours, the IBC oversees the use, storage and shipping of recombinant DNA, infectious agents and biohazardous materials in the course of research.
The IBC will:
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.